Compare CTMX & ESQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTMX | ESQ |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 977.1M | 941.0M |
| IPO Year | 2015 | 2017 |
| Metric | CTMX | ESQ |
|---|---|---|
| Price | $3.62 | $105.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | $12.10 | ★ $120.33 |
| AVG Volume (30 Days) | ★ 2.9M | 91.6K |
| Earning Date | 05-08-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.76% |
| EPS Growth | N/A | ★ 14.20 |
| EPS | N/A | ★ 1.40 |
| Revenue | ★ $76,201,000.00 | N/A |
| Revenue This Year | N/A | $35.15 |
| Revenue Next Year | $7.61 | $39.09 |
| P/E Ratio | ★ $22.58 | $75.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.72 | $87.54 |
| 52 Week High | $8.21 | $119.86 |
| Indicator | CTMX | ESQ |
|---|---|---|
| Relative Strength Index (RSI) | 30.72 | 45.08 |
| Support Level | $3.39 | $104.58 |
| Resistance Level | $3.91 | $111.41 |
| Average True Range (ATR) | 0.21 | 2.47 |
| MACD | -0.04 | -0.28 |
| Stochastic Oscillator | 5.63 | 24.78 |
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.